Captor Therapeutics Spolka Akcyjna (WSE: CTX)
Poland
· Delayed Price · Currency is PLN 57.40
+6.40 (12.55%)
Nov 20, 2024, 2:17 PM CET
CTX Market Cap
CTX has a market cap or net worth of 240.60 million as of November 21, 2024. Its market cap has decreased by -48.47% in one year.
Market Cap
240.60M
Enterprise Value
197.31M
Revenue
19.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
57.40
Market Cap Chart
Since April 19, 2021, CTX's market cap has decreased from 749.17M to 240.60M, a decrease of -67.88%. That is a compound annual growth rate of -27.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 240.60M | -47.69% |
| Dec 29, 2023 | 459.93M | -31.04% |
| Dec 30, 2022 | 666.90M | -10.15% |
| Dec 30, 2021 | 742.21M | -0.93% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Krka, d. d. | 18.44B |
| NEUCA S.A. | 3.47B |
| Sopharma AD | 2.12B |
| Synektik Spólka Akcyjna | 1.47B |
| Celon Pharma S.A. | 1.39B |
| Voxel S.A. | 1.20B |
| Ryvu Therapeutics S.A. | 1.05B |
| Selvita S.A. | 941.64M |